Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release Nov 18 2022

Nov 18, 2022 at 2:38 PM UTC · Issued by Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 18-Nov-2022 titled SEZABY�� phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

View Attachment